JV - Award for Best Belgian Sustainability Report

Van Deun A, Wright A, Zignol M, Weyer K, Rieder HL. Drug susceptibilitytesting proficiency in the network of supranational tuberculosisreference laboratories. Int J Tuberc Lung Dis 2011;15(1):116-24.Van Nieuwenhove LC, Rogé S, Balharbi F, Dieltjens T, Laurent T,Guisez Y, Büscher P, Lejon V. Identification of peptide mimotopes ofTrypanosoma brucei gambiense variant surface glycoproteins. PLoSNegl Trop Dis 2011;5(6):e1189.Van Rompaey S, Kimfuta J, Kimbondo P, Monn C, Buvé A. Operationalassessment of access to ART in rural Africa: the example of Kisantu inDemocratic Republic of the Congo. AIDS Care 2011;23(6):686-93.Vandekerckhove L, Verhofstede C, Demecheleer E, De Wit S, FlorenceE, Fransen K, Moutschen M, Mostmans W, Kabeya K, Mackie N, PlumJ, Vaira D, Van Baelen K, Vandenbroucke I, Van Eygen V, Van Marck H,Vogelaers D, Geretti AM, Stuyver LJ. Comparison of phenotypic andgenotypic tropism determination in triple-class-experienced HIVpatients eligible for maraviroc treatment. J Antimicrob Chemother2011;66(2):265-72.Vandepitte J, Muller E, Bukenya J, Nakubulwa S, Kyakuwa N, BuvéA, Weiss H, Hayes R, Grosskurth H. Prevalence and correlates ofMycoplasma genitalium infection among female sex workers inKampala, Uganda. J Infect Dis 2011;205(2):289-96.Veldhuijzen NJ, Braunstein SL, Vyankandondera J, Ingabire C,Ntirushwa J, Kestelyn E, Tuijn C, Wit FW, Umutoni A, Uwineza M, CrucittiT, van de Wijgert JHHM. The epidemiology of human papillomavirusinfection in HIV-positive and HIV-negative high-risk women in Kigali,Rwanda. BMC Infect Dis 2011;11(333):1-14.Venkatraj M, Ariën KK, Heeres J, Dirié B, Joossens J, Van Goethem S,Van der Veken P, Michiels J, Vande Velde CML, Vanham G, Lewi PJ,Augustyns K. Novel diarylpyridinones, diarylpyridazinones anddiarylphthalazinones as potential HIV-1 nonnucleoside reversetranscriptase inhibitors (NNRTIs) [letter]. Bioorg Med Chem2011;19(20):5924-34.Verhofstede C, Brudney D, Reynaerts J, Vaira D, Fransen K, De Bel A,Seguin-Devaux C, De Wit S, Vandekerckhove L, Geretti AM. Concordancebetween HIV-1 genotypic coreceptor tropism predictions based onplasma RNA and proviral DNA. HIV Med 2011;12(9):544-52.Walsh DS, Portaels F, Meyers WM. Buruli ulcer: advances inunderstanding Mycobacterium ulcerans infection. Dermatol Clin2011;29(1):1-8.Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J,Kambugu A, Manabe YC, Kestens L, Colebunders R. Antiretroviraltreatment-associated tuberculosis in a prospective cohort of HIVinfectedpatients starting ART. Clin Dev Immunol 2011;2011(758350):1-9.Worodria W, Massinga-Loembe M, Mazakpwe D, Luzinda K, MentenJ, van Leth F, Mayanja-Kizza H, Kestens L, Mugerwa RD, Reiss P,Colebunders R. Incidence and predictors of mortality and the effectof tuberculosis immune reconstitution inflammatory syndrome in acohort of TB/HIV patients commencing antiretroviral therapy. J AcquirImmune Defic Syndr 2011;58(1):32-7.Yemoa A, Gbenou J, Affolabi D, Moudachirou M, Bigot A, Anagonou S,Portaels F, Quetin-Leclercq J, Martin A. Buruli ulcer: a review of in vitrotests to screen natural products for activity against Mycobacteriumulcerans. Planta Med 2011;77(6):641-6.Zeh C, Oyaro B, Vandenhoudt H, Amornkul P, Kasembeli A, Bondo P,Mwaengo D, Thomas TK, Hart C, Laserson KF, Ondoa P, NkengasongJN. Performance of six commercial enzyme immunoassays and twoalternative HIV-testing algorithms for the diagnosis of HIV-1 infectionin Kisumu, Western Kenya. J Virol Methods 2011;176(1-2):24-31.Zeh C, Amornkul PN, Inzaule S, Ondoa P, Oyaro B, Mwaengo DM,Vandenhoudt H, Gichangi A, Williamson J, Thomas T, De Cock KM,Hart C, Nkengasong J, Laserson K. Population-based biochemistry,immunologic and hematological reference values for adolescentsand young adults in a rural population in Western Kenya. PLoS ONE2011;6(6):e21040.Zolfo M, Schapiro JM, Phan V, Koole O, Thai S, Vekemans M, Fransen K,Lynen L. Genotypic impact of prolonged detectable HIV-1 RNA viralload after HAART failure in a CRF01_AE infected cohort. AIDS Res HumRetroviruses 2011;27(7):727-35.Other publicationsAlvarez MA, Arbelaez P, Bastos FI, Berkhout B, Bhattacharya B, BocharovG, Chereshnev V, Cuchí P, Däumer M, Demikhova O, Feldmann K, GarcíaLF, Giehl C, Gulalia A, Kampmann B, Karamov E, Kebaabetswe P, KiselevM, Knellwolf AL, Kritski AL, Lange C, López-Galíndez C, Makone A,Martin A, Mayanja-Kizza H, McNerney R, Meyerhans A, Migliori GB,Morgado MG, Nachega J, Ngwira B, Odermarsky M, Ota M, PalominoJC, Pfyffer GE, Preiser W, Ritacco V, Robledo J, Rodrigues C, SalomónH, Samper S, Sanchez J, Sester M, Seth P, Seti B, Sidorovich I, SinglaR, Sonnier L, Torti C, Tortoli E, Vandevelde W, Vella S, Veloso V, vonBiesen H, Walia K, Walzl G, Wingfield C. Research priorities for HIV/M.tuberculosis co-infection. Open Infect Dis J 2011;5(Suppl. 1-M2):14-20.Ariën KK, Vanham G, Gali Y. A dual-chamber model of the femalegenital tract to evaluate epithelial toxicity of candidate anti-HIVmicrobicides. Current Protocols in Cell Biology. 52 ed. New York: Wiley;2011:26.13.1-26.13.17.Daniel O, Osman E, Bakare R, Adebiyi P, Ige O, Ogiri S, Awe A, KabirM, Ogundaunsi O, Mourad G, Declarq E. Ofloxacin resistance amongMycobacterium tuberculosis isolates in two states of south-westNigeria. Afr J Respir Med 2011;6(2):18-20.Diabaté S, Zannou DM, Geraldo N, Chamberland A, Akakpo J, AhouadaC, Massinga Loembe M, Anagonou S, Labbé AC, Alary M, Tremblay C.Antiretroviral therapy among HIV-1 infected female sex workers inBenin: a comparative study with patients from the general population.World J AIDS 2011;1(3):94-9.Durnez L, Katakweba A, Sadiki H, Katholi CR, Kazwala RR, Machang’uRR, Portaels F, Leirs H. Mycobacteria in terrestrial small mammals oncattle farms in Tanzania. Vet Med Int 2011;2011(495074):1-12.Gotuzzo Herencia E, González Lagos E, Verdonck Bosteels K, MayerArispe E, Ita Nagy F, Clark Leza D. Veinte anos de investigaciónsobre HTLV-1 y sus complicaciones médicas en el Perú: perspectivasgenerales. Acta Med Per 2010;27(3):196-203.Gotuzzo E, González E, Verdonck K. HTLV-1 in Latin America: controland perspectives. Rev Cienc Med Pernambuco 2011;7(2):[s.p.].Miller KS, Lasswell SM, Vandenhoudt H. Parent-child communicationfor youth HIV prevention in Kenya [letter to the editor in response to“Voices unheard: youth and sexuality in the wake of HIV prevention inKenya”]. Sex Reprod Healthc 2011;2(3):135.Montoro E, Lemus D, Mirabal N, Echemendia M, Madruga M, Milian Y,Díaz R, Takiff H, Martin A, Van der Stuyft P, Palomino JC. Contributions tothe diagnosis of pirazinamide resistance in Mycobacterium tuberculosis.Biotecnología Aplicada 2011; 28: 265-267.Nöstlinger C, Lusti-Narasimhan M, Mallouris C, Caswell G. Challengesof sexual health (SH) among people living with HIV (PLHIV) in Europe.Entre Nous 2011;(72): 18-19.Tebeu PM, Rochat CH, Kasia JM, Delvaux T. Perception and attitudeof obstetric fistula patients about their condition: a report fromthe Regional Hospital Maroua, Cameroon. Urogynaecologia Int J2010;24(e2):5-6.Van Gulck E, Heyndrickx L, Bracke L, Coppens S, Florence E, Buvé A,Lewi P, Vanham G. Control of viral replication after cessation of HAART.AIDS Res Ther 2011;8(6):1-5.Vanden Berghe W, Nöstlinger C, Buvé A, Beelaert G, Fransen K, LagaM. A venue-based HIV prevalence and behavioural study among menwho have sex with men in Antwerp and Ghent, Flanders, Belgium,October 2009 to March 2010. Euro Surveill 2011;16(28):pii=19914.ONDERZOEK | 63